Gliomatosis Cerebri Overview
Learn About Gliomatosis Cerebri
View Main Condition: Brain Tumor
- Gliomatosis cerebri
South Carolina Cancer Specialists
Majd Chahin is a Hematologist Oncology specialist and a Hematologist in Bluffton, South Carolina. Dr. Chahin and is rated as an Experienced provider by MediFind in the treatment of Gliomatosis Cerebri. His top areas of expertise are Myelodysplastic Syndrome (MDS), Paget Disease of the Breast, Breast Cancer, and Colorectal Cancer. Dr. Chahin is currently accepting new patients.
Andrew Pendleton is a Pediatric Hematologist Oncology specialist and a Pediatrics provider in Savannah, Georgia. Dr. Pendleton and is rated as an Experienced provider by MediFind in the treatment of Gliomatosis Cerebri. His top areas of expertise are Ependymoma, Histiocytosis, Reticulohistiocytoma, Hepatoblastoma, and Bone Marrow Aspiration. Dr. Pendleton is currently accepting new patients.
Coastal Cancer Care, LLC
Michael Hasselle is a Radiation Oncologist in Savannah, Georgia. Dr. Hasselle and is rated as an Experienced provider by MediFind in the treatment of Gliomatosis Cerebri. His top areas of expertise are Lung Cancer, Atypical Teratoid Rhabdoid Tumor (ATRT), Neuroepithelioma, Ependymoma, and Gamma Knife Radiosurgery. Dr. Hasselle is currently accepting new patients.
Summary: This study will administer the investigational drug, BDTX-1535 to eligible patients with recurrent high-grade glioma. BDTX-1535 was designed to block a growth signal important to some cancers. BDTX-1535 is being tested in this study to see if it can be given safely to people who have tumors that can be dependent on that growth signal because of changes in a protein called EGFR. These gene changes ...
Summary: Despite comprehensive multimodal treatment of newly diagnosed glioblastoma, almost all patients suffer from tumour relapse. Currently, no standard of care exists to treat these tumour relapses. Treatment options include repeated surgery (if feasible), systemic therapy (bevacizumab, lomustine, temozolomide re-challenge), reirradiation and best supportive care. Currently, the superiority of combined...
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center